| MicroRNA in disease regulation | Lifetime | 19 | US 12 | 99.85 |
| Cancer-related molecular mechanisms research | Lifetime | 29 | US 12 | 99.77 |
| Circular RNAs in diseases | Lifetime | 16 | US 8 | 99.75 |
| Extracellular vesicles in disease | Lifetime | 48 | US 18 | 99.30 |
| Mesenchymal stem cell research | Lifetime | 65 | US 30 | 99.52 |
| Epigenetics and DNA Methylation | Lifetime | 273 | US 162 | 99.19 |
| Text and Document Classification Technologies | Lifetime | 34 | US 10 | 99.01 |
| Ferroptosis and cancer prognosis | Lifetime | 132 | US 47 | 98.06 |
| Tissue Engineering and Regenerative Medicine | Lifetime | 158 | US 76 | 98.94 |
| Wound Healing and Treatments | Lifetime | 150 | US 70 | 98.77 |
| RNA modifications and cancer | Lifetime | 771 | US 385 | 98.54 |
| Immune Response and Inflammation | Lifetime | 527 | US 249 | 98.67 |
| Pharmacological Effects of Natural Compounds | Lifetime | 286 | US 47 | 97.87 |
| Nanoplatforms for cancer theranostics | Lifetime | 407 | US 59 | 98.48 |
| Cancer Cells and Metastasis | Lifetime | 408 | US 188 | 98.23 |
| Advanced Mathematical Physics Problems | Lifetime | 71 | US 21 | 98.57 |
| Autophagy in Disease and Therapy | Lifetime | 284 | US 107 | 97.96 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 784 | US 381 | 98.09 |
| Glycosylation and Glycoproteins Research | Lifetime | 709 | US 310 | 97.98 |
| RNA Interference and Gene Delivery | Lifetime | 772 | US 305 | 98.11 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 790 | US 389 | 98.35 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 346 | US 156 | 98.03 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 103 | US 47 | 97.54 |
| Traditional Chinese Medicine Analysis | Lifetime | 148 | US 6 | 97.67 |
| Cardiac Ischemia and Reperfusion | Lifetime | 319 | US 155 | 97.91 |
| Nuclear Materials and Properties | Lifetime | 528 | US 197 | 97.68 |
| Muscle Physiology and Disorders | Lifetime | 362 | US 162 | 97.86 |
| Immune cells in cancer | Lifetime | 529 | US 224 | 97.21 |
| Navier-Stokes equation solutions | Lifetime | 46 | US 18 | 98.20 |
| Metal-Organic Frameworks: Synthesis and Applications | Lifetime | 663 | US 93 | 97.96 |
| Graph Labeling and Dimension Problems | Lifetime | 69 | US 16 | 98.12 |
| Cell death mechanisms and regulation | Lifetime | 325 | US 133 | 97.52 |
| Anesthesia and Neurotoxicity Research | Lifetime | 435 | US 217 | 97.29 |
| Electrospun Nanofibers in Biomedical Applications | Lifetime | 805 | US 173 | 97.50 |
| Nutrition and Health in Aging | Lifetime | 784 | US 278 | 97.40 |
| Cancer-related Molecular Pathways | Lifetime | 821 | US 423 | 97.35 |
| Face and Expression Recognition | Lifetime | 293 | US 54 | 97.83 |
| Histone Deacetylase Inhibitors Research | Lifetime | 392 | US 205 | 96.39 |
| Technology and Security Systems | Lifetime | 27 | US 1 | 90.96 |
| Adsorption and biosorption for pollutant removal | Lifetime | 660 | US 40 | 97.09 |
| Inflammasome and immune disorders | Lifetime | 411 | US 120 | 96.22 |
| Nitric Oxide and Endothelin Effects | Lifetime | 817 | US 366 | 97.09 |
| Biochemical effects in animals | Lifetime | 597 | US 226 | 96.30 |
| Diabetes Treatment and Management | Lifetime | 834 | US 310 | 97.18 |
| Image Retrieval and Classification Techniques | Lifetime | 457 | US 114 | 97.35 |
| Radioactive element chemistry and processing | Lifetime | 893 | US 309 | 96.36 |
| NF-κB Signaling Pathways | Lifetime | 429 | US 178 | 96.19 |
| Nanoparticle-Based Drug Delivery | Lifetime | 918 | US 168 | 96.84 |
| Advanced Nanomaterials in Catalysis | Lifetime | 855 | US 43 | 96.64 |
| Carbon and Quantum Dots Applications | Lifetime | 397 | US 16 | 95.64 |
| Ginseng Biological Effects and Applications | Lifetime | 278 | US 19 | 95.56 |
| Angiogenesis and VEGF in Cancer | Lifetime | 768 | US 330 | 95.79 |
| Cardiovascular Disease and Adiposity | Lifetime | 891 | US 405 | 95.91 |
| Graph theory and applications | Lifetime | 155 | US 32 | 96.50 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 87 | US 11 | 93.05 |
| Cardiac Fibrosis and Remodeling | Lifetime | 315 | US 120 | 95.68 |
| Retinoids in leukemia and cellular processes | Lifetime | 587 | US 302 | 95.63 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 420 | US 71 | 93.15 |
| Chemokine receptors and signaling | Lifetime | 391 | US 158 | 94.76 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 851 | US 364 | 95.17 |
| Advanced Graph Theory Research | Lifetime | 289 | US 94 | 96.52 |
| S100 Proteins and Annexins | Lifetime | 625 | US 278 | 94.68 |
| Seed and Plant Biochemistry | Lifetime | 265 | US 19 | 94.38 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 901 | US 433 | 95.44 |
| Ion Transport and Channel Regulation | Lifetime | 585 | US 296 | 95.32 |
| FOXO transcription factor regulation | Lifetime | 150 | US 85 | 92.87 |
| Planarian Biology and Electrostimulation | Lifetime | 113 | US 52 | 93.71 |
| Sulfur Compounds in Biology | Lifetime | 479 | US 148 | 94.51 |
| Cancer Mechanisms and Therapy | Lifetime | 781 | US 309 | 93.02 |
| Fibroblast Growth Factor Research | Lifetime | 562 | US 234 | 93.35 |
| Photodynamic Therapy Research Studies | Lifetime | 759 | US 170 | 93.79 |
| Advanced Materials and Mechanics | Lifetime | 731 | US 177 | 93.79 |
| Genomics, phytochemicals, and oxidative stress | Lifetime | 943 | US 305 | 93.46 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 743 | US 346 | 93.46 |
| Proteoglycans and glycosaminoglycans research | Lifetime | 817 | US 323 | 93.80 |
| Machine Learning in Bioinformatics | Lifetime | 565 | US 156 | 93.49 |
| Signaling Pathways in Disease | Lifetime | 919 | US 419 | 92.43 |
| Silymarin and Mushroom Poisoning | Lifetime | 99 | US 23 | 91.25 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 628 | US 272 | 90.62 |
| Sphingolipid Metabolism and Signaling | Lifetime | 624 | US 234 | 91.93 |
| Yersinia bacterium, plague, ectoparasites research | Lifetime | 871 | US 308 | 90.94 |
| Connexins and lens biology | Lifetime | 890 | US 394 | 91.87 |
| Hydrogen's biological and therapeutic effects | Lifetime | 272 | US 48 | 86.27 |
| Burn Injury Management and Outcomes | Lifetime | 646 | US 331 | 90.17 |
| Plant-based Medicinal Research | Lifetime | 924 | US 194 | 87.48 |
| Mechanisms of cancer metastasis | Lifetime | 215 | US 75 | 84.75 |
| Aldose Reductase and Taurine | Lifetime | 660 | US 244 | 86.83 |
| Embedded Systems and FPGA Design | Lifetime | 486 | US 28 | 78.43 |
| Limits and Structures in Graph Theory | Lifetime | 678 | US 181 | 84.78 |
| Forest, Soil, and Plant Ecology in China | Lifetime | 959 | US 30 | 76.57 |
| Calpain Protease Function and Regulation | Lifetime | 819 | US 284 | 75.23 |
| Magnolia and Illicium research | Lifetime | 819 | US 94 | 42.55 |
| MicroRNA in disease regulation | 2021-2025 | 16 | US 2 | 99.67 |
| Cancer-related molecular mechanisms research | 2021-2025 | 43 | US 4 | 99.57 |
| Image Retrieval and Classification Techniques | 2021-2025 | 8 | US 1 | 98.68 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 68 | US 19 | 97.51 |
| Epigenetics and DNA Methylation | 2021-2025 | 110 | US 39 | 97.53 |
| Circular RNAs in diseases | 2021-2025 | 55 | US 3 | 98.36 |
| Text and Document Classification Technologies | 2021-2025 | 12 | US 2 | 98.20 |
| Seed and Plant Biochemistry | 2021-2025 | 17 | US 1 | 97.04 |
| Ferroptosis and cancer prognosis | 2021-2025 | 158 | US 19 | 97.30 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 390 | US 156 | 98.50 |
| Advanced Topology and Set Theory | 2021-2025 | 8 | US 1 | 95.64 |
| Immune cells in cancer | 2021-2025 | 181 | US 31 | 96.10 |
| Inflammasome and immune disorders | 2021-2025 | 92 | US 23 | 95.82 |
| Extracellular vesicles in disease | 2021-2025 | 201 | US 21 | 96.37 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 345 | US 9 | 97.71 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 273 | US 82 | 94.99 |
| Planarian Biology and Electrostimulation | 2021-2025 | 11 | US 6 | 92.80 |
| RNA modifications and cancer | 2021-2025 | 582 | US 103 | 95.44 |
| Tryptophan and brain disorders | 2021-2025 | 219 | US 50 | 95.43 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 205 | US 52 | 93.94 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 46 | US 11 | 92.33 |
| Cancer-related gene regulation | 2021-2025 | 155 | US 33 | 92.51 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 199 | US 58 | 92.65 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 614 | US 198 | 95.71 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 712 | US 248 | 94.34 |
| Hip and Femur Fractures | 2021-2025 | 259 | US 59 | 93.68 |
| Immune Response and Inflammation | 2021-2025 | 200 | US 53 | 89.70 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 522 | US 174 | 92.22 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 458 | US 158 | 93.46 |
| Ionic liquids properties and applications | 2021-2025 | 285 | US 26 | 92.90 |
| Esophageal and GI Pathology | 2021-2025 | 526 | US 140 | 93.02 |
| Adsorption and biosorption for pollutant removal | 2021-2025 | 630 | US 16 | 93.09 |
| Microbial Metabolites in Food Biotechnology | 2021-2025 | 261 | US 7 | 92.61 |
| Advanced Graph Theory Research | 2021-2025 | 107 | US 16 | 93.21 |
| Cancer-related Molecular Pathways | 2021-2025 | 203 | US 89 | 89.95 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 327 | US 95 | 90.57 |
| Tracheal and airway disorders | 2021-2025 | 573 | US 194 | 90.43 |
| Peptidase Inhibition and Analysis | 2021-2025 | 593 | US 148 | 90.28 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 856 | US 262 | 91.60 |
| Single-cell and spatial transcriptomics | 2021-2025 | 639 | US 288 | 89.00 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 371 | US 78 | 90.24 |
| Animal Virus Infections Studies | 2021-2025 | 618 | US 138 | 88.40 |
| Pregnancy and preeclampsia studies | 2021-2025 | 918 | US 238 | 89.96 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 788 | US 46 | 89.60 |
| Asthma and respiratory diseases | 2021-2025 | 985 | US 234 | 91.68 |
| Lung Cancer Research Studies | 2021-2025 | 896 | US 269 | 90.30 |
| Bone health and osteoporosis research | 2021-2025 | 359 | US 62 | 88.73 |
| Dermatology and Skin Diseases | 2021-2025 | 742 | US 170 | 89.60 |
| Membrane Separation and Gas Transport | 2021-2025 | 415 | US 27 | 90.44 |
| Mesenchymal stem cell research | 2021-2025 | 544 | US 77 | 86.84 |
| Cardiac electrophysiology and arrhythmias | 2021-2025 | 966 | US 255 | 89.37 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 678 | US 156 | 89.83 |
| Hormonal Regulation and Hypertension | 2021-2025 | 470 | US 112 | 87.01 |
| Ubiquitin and proteasome pathways | 2021-2025 | 676 | US 169 | 84.69 |
| Wound Healing and Treatments | 2021-2025 | 841 | US 90 | 87.28 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 156 | US 39 | 82.83 |
| Carbon and Quantum Dots Applications | 2021-2025 | 720 | US 22 | 86.62 |
| Spectroscopy Techniques in Biomedical and Chemical Research | 2021-2025 | 543 | US 56 | 86.34 |
| Phagocytosis and Immune Regulation | 2021-2025 | 281 | US 89 | 80.51 |
| Lipid metabolism and biosynthesis | 2021-2025 | 245 | US 53 | 83.13 |
| Advanced Image and Video Retrieval Techniques | 2021-2025 | 875 | US 29 | 87.65 |
| Limits and Structures in Graph Theory | 2021-2025 | 103 | US 27 | 86.53 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 902 | US 114 | 84.12 |
| Plant Gene Expression Analysis | 2021-2025 | 883 | US 38 | 83.02 |
| Cancer therapeutics and mechanisms | 2021-2025 | 543 | US 122 | 80.32 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 624 | US 298 | 81.72 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 586 | US 139 | 79.88 |
| Urticaria and Related Conditions | 2021-2025 | 552 | US 106 | 82.71 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 809 | US 241 | 81.80 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 957 | US 235 | 78.85 |
| Congenital Ear and Nasal Anomalies | 2021-2025 | 42 | US 13 | 73.97 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 347 | US 43 | 80.45 |
| Ion channel regulation and function | 2021-2025 | 660 | US 231 | 80.42 |
| Photodynamic Therapy Research Studies | 2021-2025 | 661 | US 55 | 81.59 |
| Face and Expression Recognition | 2021-2025 | 447 | US 19 | 83.22 |
| ECG Monitoring and Analysis | 2021-2025 | 755 | US 116 | 80.66 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 636 | US 125 | 78.15 |
| Congenital heart defects research | 2021-2025 | 638 | US 252 | 76.69 |
| Cryptography and Data Security | 2021-2025 | 762 | US 68 | 82.89 |
| Parvovirus B19 Infection Studies | 2021-2025 | 273 | US 72 | 76.36 |
| Erythrocyte Function and Pathophysiology | 2021-2025 | 509 | US 171 | 78.17 |
| Cell Adhesion Molecules Research | 2021-2025 | 597 | US 151 | 74.83 |
| Chaos-based Image/Signal Encryption | 2021-2025 | 658 | US 14 | 82.03 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 419 | US 105 | 75.41 |
| Signaling Pathways in Disease | 2021-2025 | 217 | US 58 | 72.28 |
| Dysphagia Assessment and Management | 2021-2025 | 972 | US 280 | 77.92 |
| Ginseng Biological Effects and Applications | 2021-2025 | 498 | US 17 | 77.27 |
| Machine Learning in Bioinformatics | 2021-2025 | 423 | US 69 | 79.30 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 311 | US 42 | 74.41 |
| Bipolar Disorder and Treatment | 2021-2025 | 997 | US 199 | 78.81 |
| Invertebrate Immune Response Mechanisms | 2021-2025 | 613 | US 76 | 75.93 |
| Neonatal Health and Biochemistry | 2021-2025 | 551 | US 154 | 70.77 |
| Graph Labeling and Dimension Problems | 2021-2025 | 324 | US 29 | 74.81 |
| Adenosine and Purinergic Signaling | 2021-2025 | 616 | US 101 | 69.53 |
| Biochemical effects in animals | 2021-2025 | 833 | US 54 | 70.18 |
| Cryptography and Residue Arithmetic | 2021-2025 | 133 | US 24 | 69.33 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 756 | US 25 | 67.07 |
| Chaos control and synchronization | 2021-2025 | 595 | US 20 | 70.92 |
| Fibroblast Growth Factor Research | 2021-2025 | 648 | US 194 | 63.60 |
| Toxin Mechanisms and Immunotoxins | 2021-2025 | 657 | US 100 | 62.85 |
| Digestive system and related health | 2021-2025 | 704 | US 111 | 63.92 |
| Sodium Intake and Health | 2021-2025 | 772 | US 177 | 62.16 |
| Phonocardiography and Auscultation Techniques | 2021-2025 | 542 | US 71 | 62.22 |
| Burn Injury Management and Outcomes | 2021-2025 | 727 | US 237 | 61.17 |
| Graph theory and applications | 2021-2025 | 714 | US 46 | 63.37 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 688 | US 178 | 60.67 |
| Kruppel-like factors research | 2021-2025 | 561 | US 117 | 59.46 |
| Wildlife-Road Interactions and Conservation | 2021-2025 | 828 | US 115 | 59.61 |
| Heavy Metals in Plants | 2021-2025 | 710 | US 19 | 58.67 |
| Sphingolipid Metabolism and Signaling | 2021-2025 | 743 | US 196 | 58.08 |
| ATP Synthase and ATPases Research | 2021-2025 | 970 | US 244 | 56.74 |
| Nuts composition and effects | 2021-2025 | 713 | US 60 | 56.62 |
| Oral health in cancer treatment | 2021-2025 | 928 | US 126 | 55.66 |
| Cell death mechanisms and regulation | 2021-2025 | 608 | US 110 | 53.49 |
| Plant-based Medicinal Research | 2021-2025 | 497 | US 24 | 55.45 |
| Healthcare and Venom Research | 2021-2025 | 775 | US 34 | 54.52 |
| Chemokine receptors and signaling | 2021-2025 | 728 | US 148 | 54.00 |
| graph theory and CDMA systems | 2021-2025 | 978 | US 73 | 54.05 |
| Plant and Biological Electrophysiology Studies | 2021-2025 | 370 | US 65 | 51.99 |
| Fullerene Chemistry and Applications | 2021-2025 | 952 | US 66 | 53.70 |
| Berberine and alkaloids research | 2021-2025 | 519 | US 33 | 50.19 |
| Barrier Structure and Function Studies | 2021-2025 | 792 | US 216 | 48.56 |
| Environmental Changes in China | 2021-2025 | 316 | US 7 | 46.90 |
| Caveolin-1 and cellular processes | 2021-2025 | 291 | US 80 | 47.36 |
| Peanut Plant Research Studies | 2021-2025 | 763 | US 147 | 43.02 |
| Magnolia and Illicium research | 2021-2025 | 113 | US 11 | 41.35 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 902 | US 78 | 34.63 |